J&J

J&J Expands U.S. Footprint With $1B+ Investment In Next-Gen Cell Therapy Facility In Pennsylvania

J&J Expands U.S. Footprint With $1B+ Investment In Next-Gen Cell Therapy Facility In Pennsylvania

12 hours ago

1 min read

BMS & J&J Launch “Change the Target, Change What’s Possible” To Tackle Cardiovascular & Thromboembolic Care Gaps

BMS & J&J Launch “Change the Target, Change What’s Possible” To Tackle Cardiovascular & Thromboembolic Care Gaps

05 Feb 2026

2 min read

J&J Real-World Evidence Favors Apalutamide Over Darolutamide For Survival In Metastatic Prostate Cancer Treatment

J&J Real-World Evidence Favors Apalutamide Over Darolutamide For Survival In Metastatic Prostate Cancer Treatment

03 Feb 2026

2 min read

Read More

Voice Of HealthCare

vohnetwork.com